Literature DB >> 8244493

Refractory anaemias.

A K Saraya1, P S Dhot, R Saxena.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8244493     DOI： 10.1007/bf02822174

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  20 in total

1.  Autoimmune myelodysplasias.

Authors:  P A Miescher; H Favre; P Beris
Journal:  Semin Hematol       Date:  1991-10       Impact factor: 3.851

2.  Leukemia following chemotherapy for ovarian cancer.

Authors:  J M Kaldor; N E Day; F Pettersson; E A Clarke; D Pedersen; W Mehnert; J Bell; H Høst; P Prior; S Karjalainen
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

3.  Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow-up.

Authors:  M M de Planque; J H van Krieken; H C Kluin-Nelemans; L P Colla; F van der Burgh; A Brand; P M Kluin
Journal:  Br J Haematol       Date:  1989-07       Impact factor: 6.998

4.  Very-low-dose cytarabine for myelodysplastic syndromes and acute myeloid leukaemia in the elderly.

Authors:  A Worsley; G J Mufti; J A Copplestone; D G Oscier; T J Hamblin
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

5.  Low doses of cytarabine in the treatment of myelodysplastic syndrome and acute myeloid leukemia.

Authors:  G J Mufti; D G Oscier; T J Hamblin; A J Bell
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

6.  Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

Authors:  T De Witte; F Zwaan; J Hermans; J Vernant; H Kolb; J Vossen; B Lönnqvist; D Beelen; A Ferrant; J Gmür
Journal:  Br J Haematol       Date:  1990-02       Impact factor: 6.998

7.  Treatment of preleukemic syndromes with marrow transplantation.

Authors:  F R Appelbaum; R Storb; R E Ramberg; H M Shulman; C D Buckner; R A Clift; H J Deeg; A Fefer; J Sanders; S Self
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

8.  Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults.

Authors:  M M de Planque; H C Kluin-Nelemans; H J van Krieken; P M Kluin; A Brand; G C Beverstock; R Willemze; J J van Rood
Journal:  Br J Haematol       Date:  1988-09       Impact factor: 6.998

9.  Second malignancies in patients with multiple myeloma.

Authors:  I P Law; J Blom
Journal:  Oncology       Date:  1977       Impact factor: 2.935

10.  Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

Authors:  J J Yunis; M Lobell; M A Arnesen; M M Oken; M G Mayer; R E Rydell; R D Brunning
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.